2014;130(14):1452-4. . Arvio M, Bjelogrlic-Laakso N, Salokivi T. Abstract Cannabinoid was licensed in 2012 for the treatment of…
Freedom WaresAugust 28, 2014
2014 Mar 17;176(12A). pii: V09130552. Basinski H1, Jensen HB, Stenager E. Author information Abstract We identified 16…
Freedom WaresMarch 17, 2014
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis. Lorente Fernández L, Monte Boquet E, Pérez-Miralles F, Gil Gómez…
Freedom WaresSeptember 17, 2013
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. García-Merino A.…
Freedom WaresAugust 6, 2013
Journal of Neurology J Neurol. 2013 February; 260(2): 351–367. Published online 2012 July 4. doi: 10.1007/s00415-012-6579-2 PMCID: PMC3566383 A mechanism-based…
Freedom WaresAugust 3, 2013
2012 Apr;1(2):64-75. doi: 10.1016/j.msard.2011.11.001. Epub 2012 Jan 18. Baker D1, Pryce G2, Jackson SJ2, Bolton C2, Giovannoni G2. Author…
Freedom WaresApril 18, 2012
2011 Apr;6(4):437-52. doi: 10.1517/17460441.2011.560935. Epub 2011 Mar 3. A drug discovery case history of 'delta-9-tetrahydrocannabinol,…
Freedom WaresApril 6, 2011
2006;66(2):234-46. Epub 2005 Oct 4. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Russo…
Freedom WaresOctober 4, 2005